Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

InMed Pharmaceuticals Inc.

NASDAQ: MTRI · Life Sciences · 12 alerts · CIK 1728328

Share price
$19.87Close, Nov 16
Market cap
$109M
Shares outstanding
5.49MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All InMed Pharmaceuticals Inc. filings on SEC EDGAR ↗

6:03 AM ET 10-Q
Financial Results

InMed Pharmaceuticals Q1 2026 Results: Net Loss of $2.33M, Loss Widens

InMed Pharmaceuticals Inc. reported its financial results for the quarter ended September 30, 2026, highlighting ongoing research and development expenses related to its cannabinoid-based pipeline. The company continues to manage its cash position to fund clinical trials and proprietary manufacturing technology development.

Key figure
Net loss $2.33M

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.